Searched for
ASTRAZENECA STUDY
Moderna and other groups get $60 million to develop Ebola vaccineCEPI is investing around $60 million to speed up the creation of vaccines against the deadly Ebola Bundibugyo virus. This funding will supp...- Novartis experimental actinium-based drug shows promise in prostate cancer treatment: StudyNovartis' new experimental actinium-based drug shows promise against prostate cancer. Early data on Sunday revealed anti-tumour activity, e...
- What to know about the Bundibugyo virus, a species of Ebola causing an outbreak in CongoA rare Bundibugyo virus outbreak in Congo, with over 200 deaths, lacks specific treatments or vaccines, complicating response efforts. Whil...
- Chinese medicines bring relief to India’s cancer patientsIndia’s cancer treatment landscape is seeing a shift as lower-cost immunotherapy drugs developed in China and marketed through Indian partn...
- Study links AstraZeneca's Covid vaccine to higher risk of very rare clotSeveral countries have already altered their advice after previous research indicated that, in rare number of cases, thrombosis with thromb...
- AstraZeneca Covid booster shot effective against severe disease, UK study findsThe researchers from the UK Health Security Agency, London, estimated vaccine effectiveness by analysing data on all adults aged 18 years a...
- RDIF says early results of 'mix & match' of Sputnik Light, AstraZeneca jab found to be safeAstraZeneca COVID vaccine is the same as Covishield which is used in India and several other countries.
- Germany recommends combination of AstraZeneca, mRNA shotsThe committee, known by its German acronym STIKO, didn't detail what studies its conclusion was based on. Germany's disease control center ...
- One in four people experience mild side effects from Covishield COVID-19 vaccine: Lancet studyThe researchers from King's College London in the UK also found that most systemic side effects -- meaning side effects excluding where the...
- AstraZeneca could have COVID-19 vaccine against variant by end-2021 -Austrian newspaperSarah Walters, AstraZeneca's Austria country manager, told the Kurier newspaper that studies, so far, indicating the existing AstraZeneca v...
- Reputation of AstraZeneca's COVID vaccine marred by missteps"The way they handled their data early on, AstraZeneca basically shot themselves in the foot," Julian Tang, a virologist at the University ...
- AstraZeneca says US trial data shows vaccine 79% effectiveThe U.S. study comprised 30,000 volunteers, 20,000 of whom were given the vaccine while the rest got dummy shots. The results were announed...
- Oxford study indicates AstraZeneca effective against Brazil variant, source saysThe data indicates that the vaccine will not need to be modified in order to protect against the variant, which is believed to have origina...
- AstraZeneca to test combining COVID-19 vaccine with Russian shotThe developers of Sputnik V suggested on Twitter last month that AstraZeneca try the combination.
- AstraZeneca inks pact with Research Society for Study of Diabetes in IndiaAs a key facet of this association, the company has unveiled a three-year patient awareness programme, 'Beyond Sugar', developed to benefit...
- India trials of COVID-19 vaccine is going on: Serum InstituteLast month, the Drug Controller General of India had granted permission to the Pune-based SII to conduct Phase-II and -III human clinical t...
- Oxford Covid-19 vaccine trial paused after unexplained illness, says AstraZenecaLate last month, AstraZeneca began recruiting 30,000 people in the US for its largest study of the vaccine. It also is testing the vaccine,...
- AstraZeneca plunges 13% as Covid-19 drug trial put on holdAstraZeneca began its Phase 3 trial in the US in late August. The US trial was currently taking place at 62 sites across the country.
- Good cancer drug data helps AstraZeneca in Pfizer fightBritain's second-biggest drugmaker has rejected a $106 billion approach from its US rival Pfizer, arguing that it has a bright future.
- Cognizant inks multi-year agreement with AstraZenecaCognizant has inked a deal with AstraZeneca to deliver comprehensive biostatistics and medical reporting services for generating clinical s...
Load More
